Kolon Life Science Inc. (KOSDAQ:102940)

South Korea · Delayed Price · Currency is KRW

16,380

+780 (5.00%)

Aug 10, 2026, 3:30 PM KST

Kolon Life Science Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	213,806	208,982	161,387	124,639	161,584	165,485
Revenue Growth	27.52%	29.49%	29.48%	-22.86%	-2.36%	27.87%
Gross Profit	60,049	55,778	16,744	12,296	37,017	37,104
Operating Income	20,415	17,572	-22,084	-24,095	2,642	4,249
Net Income	35,327	24,960	-93,086	-30,726	2,133	-1,375
Earnings Per Share	2498.04	1824.00	-7794.00	-2692.37	169.00	-121.00
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	9,609	10,636	12,498	7,561	6,371	27,910
Total Debt	111,384	103,730	126,598	107,863	73,916	68,925
Net Cash (Debt)	-101,776	-93,094	-114,100	-100,301	-67,545	-41,015
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6964.64	-6496.63	-9553.48	-8788.83	-5344.94	-3597.74

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	2,778	10,209	-14,085	-24,866	-20,854	-16,187
Capital Expenditures	-27,312	-38,264	-8,194	-10,144	-6,305	-4,413
Free Cash Flow	-24,533	-28,055	-22,279	-35,009	-27,159	-20,600
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	28.09%	26.69%	10.38%	9.87%	22.91%	22.42%
Operating Margin	9.55%	8.41%	-13.68%	-19.33%	1.64%	2.57%
Pretax Margin	16.88%	12.32%	-57.68%	-26.96%	2.55%	-2.42%
Profit Margin	16.52%	11.94%	-57.68%	-24.65%	1.32%	-0.83%
FCF Margin	-11.47%	-13.43%	-13.80%	-28.09%	-16.81%	-12.45%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	6.56	26.73	-	-	146.58	-
Forward PE	-	30.73	30.73	30.73	30.73	30.73
PS Ratio	1.00	3.19	1.77	2.35	1.94	2.98